| Literature DB >> 26418015 |
Moritz Schumann1, Kaisu Yli-Peltola1, Chris R Abbiss2, Keijo Häkkinen1.
Abstract
This study investigated the effects of endurance followed by strength training (ES, men n = 16; women n = 15), the reverse exercise order (SE, men n = 18, women n = 13) and concurrent endurance and strength training performed on alternating days (AD, men n = 21, women n = 18) on cardiorespiratory parameters. Peak oxygen consumption ([Formula: see text]O2peak) and oxygen consumption at sub-maximal power outputs ([Formula: see text]O2submax) of 50 to 175 Watts in men and 50 to 125 Watts in women were assessed during an incremental cycling test both before and after 24 weeks of training. Increases in [Formula: see text]O2peak in both men and women were statistically larger in AD (18±9% and 25±11%) compared to ES (7±9% and 12±12%, p = 0.002 and 0.009, respectively) and SE (7±9% and 10±8%, p = 0.005 and 0.008, respectively). No statistical group interaction was observed for [Formula: see text]O2submax in men, but in women [Formula: see text]O2submax was statistically lower at week 24 in ES compared to AD at 75 W (-2±6% vs. +3±6%, p = 0.027) and 125 W (-4±5% vs. +2±5%, p = 0.010). These findings indicate that endurance and strength training performed on alternating days may optimize the adaptations in [Formula: see text]O2peak in both sexes, while performing ES training in women may optimize cardiorespiratory fitness at sub-maximal power outputs.Entities:
Mesh:
Year: 2015 PMID: 26418015 PMCID: PMC4587735 DOI: 10.1371/journal.pone.0139279
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Anthropometrics of subjects within ES, SE and AD.
| Age (y) | Body mass (kg) | Height (cm) | BMI | ||
|---|---|---|---|---|---|
|
|
| 30±6 | 81±12 | 178±6 | 25±3 |
|
| 30±4 | 76±9 | 179±5 | 24±2 | |
|
| 29±6 | 82±11 | 180±7 | 26±4 | |
|
|
| 30±5 | 68±11 | 168±6 | 24±3 |
|
| 29±4 | 63±8 | 164±5 | 24±4 | |
|
| 30±8 | 68±9 | 168±5 | 24±3 |
Peak oxygen consumption, peak wattage and 1RM strength in dynamic leg press prior to (0), at 12 weeks and at 24 weeks following ES, SE and AD.
| Week 0 | Week 12 | Week 24 | ||
|---|---|---|---|---|
|
|
| |||
|
| 3.38±0.50 | 3.54±0.48 | 3.59±0.55 | |
|
| 42.2±7.2 | 44.0±6.3 | 44.6±5.1 | |
|
| 126.07±19.5 | 131.6±17.3 | 133.3±15.2 | |
| Peak wattage (W) | 268±39 | 287±38 | 300±38 | |
| 1 RM (kg) | 157±30 | 170±27 | 175±27 | |
|
| ||||
|
| 3.20±0.44 | 3.44±0.41 | 3.42±0.35 | |
|
| 42.5±7.0 | 45.2±6.9 | 45.3±6.9 | |
|
| 125.0±19.0 | 133.4±18.2 | 133.3±17.9 | |
| Peak wattage (W) | 245±35 | 268±37 | 284±37 | |
| 1 RM (kg) | 143±23 | 160±21 | 166±20 | |
|
| ||||
|
| 2.92±0.36 | 3.30±0.34 | 3.39±0.34 | |
|
| 36.2±6.5 | 40.1±6.3 | 42.4±6.6 | |
|
| 108.4±17.0 | 122.1±17.3 | 126.5±16.8 | |
| Peak wattage (W) | 233±30 | 264±25 | 279±28 | |
| 1 RM (kg) | 142±24 | 156±21 | 159±22 | |
|
|
| |||
|
| 2.07±0.36 | 2.23±0.34 | 2.31±0.27 | |
|
| 30.7±3.8 | 33.0±4.3 | 34.0±4.0 | |
|
| 87.7±10.7 | 94.0±11.1 | 97.5±9.7 | |
| Peak wattage (W) | 170±26 | 189±25 | 204±23 | |
| 1 RM (kg) | 102±22 | 109±23 | 115±23 | |
|
| ||||
|
| 2.12±0.32 | 2.29±0.29 | 2.35±0.28 | |
|
| 33.8±4.7 | 36.1±5.3 | 36.9±4.8 | |
|
| 94.9±12.4 | 101.7±12.9 | 104.1±11.7 | |
| Peak wattage (W) | 182±27 | 192±25 | 210±26 | |
| 1 RM (kg) | 100±18 | 109±18 | 116±17 | |
|
| ||||
|
| 1.86±0.25 | 2.14±0.22 | 2.26±0.23 | |
|
| 27.9±5.8 | 32.1±4.8 | 34.7±5.8 | |
|
| 79.6±13.5 | 91.6±11.9 | 98.5±13.8 | |
| Peak wattage (W) | 155±25 | 179±20 | 188±29 | |
| 1 RM (kg) | 88±12 | 103±14 | 106±14 |
*≤0.05 compared to corresponding value of week 0
§ p≤0.05 compared to corresponding value of week 12
† p≤0.05 value at week 0 and change at week 12 or 24 compared to AD
# statistical trend p≤0.06
Sub-maximal oxygen consumption (O2) during the incremental cycling test performed prior to (0), at 12 weeks and at 24 weeks following ES, SE and AD.
|
| |||||||
|---|---|---|---|---|---|---|---|
| 50W | 75W | 100W | 125W | 150W | 175W | ||
|
|
| ||||||
| 0 | 1.05±0.07 | 1.29±0.07 | 1.52±0.08 | 1.77±0.07 | 2.01±0.08 | 2.31±0.09 | |
| 12 | 1.06±0.10 | 1.27±0.10 | 1.49±0.09 | 1.72±0.09 | 1.99±0.10 | 2.26±0.10 | |
| 24 | 1.05±0.12 | 1.28±0.10 | 1.49±0.09 | 1.72±0.11 | 1.95±0.13 | 2.23±0.12 | |
|
| |||||||
| 0 | 1.03±0.10 | 1.25±0.08 | 1.47±0.08 | 1.76±0.08 | 2.06±0.08 | 2.33±0.09 | |
| 12 | 1.08±0.08 | 1.30±0.07 | 1.52±0.07 | 1.76±0.06 | 2.02±0.06 | 2.32±0.07 | |
| 24 | 1.01±0.07 | 1.25±0.08 | 1.48±0.09 | 1.70±0.09 | 1.95±0.09 | 2.26±0.07 | |
|
| |||||||
| 0 | 1.01±0.06 | 1.20±0.09 | 1.45±0.09 | 1.71±0.10 | 1.97±0.12 | 2.25±0.12 | |
| 12 | 1.04±0.09 | 1.25±0.07 | 1.46±0.05 | 1.71±0.07 | 1.96±0.06 | 2.21±0.06 | |
| 24 | 1.00±0.06 | 1.23±0.07 | 1.46±0.08 | 1.68±0.09 | 1.94±0.06 | 2.18±0.07 | |
|
|
| ||||||
| 0 | 0.93±0.08 | 1.13±0.08 | 1.36±0.05 | 1.63±0.07 | |||
| 12 | 0.91±0.08 | 1.13±0.10 | 1.34±0.08 | 1.58±0.12 | |||
| 24 | 0.92±0.09 | 1.12±0.10 | 1.35±0.09 | 1.57±0.10 | |||
|
| |||||||
| 0 | 0.91±0.07 | 1.13±0.08 | 1.36±0.09 | 1.61±0.10 | |||
| 12 | 0.96±0.08 | 1.17±0.09 | 1.41±0.10 | 1.65±0.11 | |||
| 24 | 0.93±0.07 | 1.13±0.09 | 1.37±0.08 | 1.60±0.11 | |||
|
| |||||||
| 0 | 0.91±0.06 | 1.12±0.06 | 1.35±0.06 | 1.60±0.06 | |||
| 12 | 0.92±0.06 | 1.11±0.05 | 1.32±0.05 | 1.56±0.06 | |||
| 24 | 0.92±0.07 | 1.13±0.05 | 1.35±0.05 | 1.59±0.06 | |||
* p≤0.05 compared to corresponding values of week 0
# statistical trend p≤0.07 compared to corresponding values of week 0
† p≤0.05 change from week 0 compared to AD
• p≤0.05 change from week 0 compared to SE
Fig 1Oxygen consumption at sub-maximal power outputs in men (A) and women (B).
* p<0.05; within the bar compared to corresponding value at week 0, outside the bar as indicated.
Gross efficiency during the incremental cycling test performed prior to (0), at 12 weeks and at 24 weeks following ES, SE and AD.
| Gross efficiency (%) | |||||||
|---|---|---|---|---|---|---|---|
| 50W | 75W | 100W | 125W | 150W | 175W | ||
|
|
| ||||||
| 0 | 14.1±1.0 | 16.9±1.0 | 18.9±0.9 | 20.2±0.7 | 21.1±0.9 | 21.3±0.9 | |
| 12 | 14.0±1.2 | 17.3±1.4 | 19.4±1.1 | 20.9±1.1 | 21.6±1.0 | 22.0±0.9 | |
| 24 | 14.1±1.5 | 17.2±1.2 | 19.4±1.1 | 20.9±1.3 | 21.9±1.4 | 22.2±1.1 | |
|
| |||||||
| 0 | 14.2±1.2 | 17.3±1.0 | 19.4±0.9 | 20.1±0.9 | 20.5±0.8 | 21.0±0.9 | |
| 12 | 13.6±1.1 | 16.8±0.9 | 19.0±0.8 | 20.3±0.6 | 21.0±0.6 | 21.2±0.5 | |
| 24 | 14.5±1.1 | 17.5±1.1 | 19.4±1.2 | 20.9±1.2 | 21.8±1.1 | 21.8±0.6 | |
|
| |||||||
| 0 | 14.5±0.9 | 18.1±1.4 | 19.7±1.3 | 20.6±1.3 | 21.3±1.5 | 21.6±1.4 | |
| 12 | 14.1±1.3 | 17.3±1.0 | 19.6±0.8 | 20.7±1.0 | 21.6±0.7 | 22.2±0.7 | |
| 24 | 14.6±1.0 | 17.8±1.2 | 19.7±1.2 | 21.2±1.3 | 21.9±0.7 | 22.5±0.8 | |
|
|
| ||||||
| 0 | 15.9±1.3 | 19.0±1.2 | 20.7±0.7 | 21.3±0.8 | |||
| 12 | 16.3±1.5 | 19.3±1.6 | 21.2±1.1 | 22.2±1.3 | |||
| 24 | 16.0±1.9 | 19.4±1.8 | 21.1±1.5 | 22.3±1.4 | |||
|
| |||||||
| 0 | 16.2±1.4 | 19.3±1.4 | 21.0±1.5 | 21.7±1.5 | |||
| 12 | 15.4±1.3 | 18.6±1.4 | 20.3±1.2 | 21.3±1.2 | |||
| 24 | 15.9±1.3 | 19.3±1.5 | 20.9±1.2 | 22.1±1.4 | |||
|
| |||||||
| 0 | 16.1±1.0 | 19.2±1.0 | 20.8±0.9 | 21.6±0.8 | |||
| 12 | 16.0±1.0 | 19.5±0.9 | 21.3±0.9 | 22.3±0.9 | |||
| 24 | 16.0±1.1 | 19.1±0.8 | 21.0±0.7 | 22.0±0.8 | |||
* p≤0.05 compared to corresponding values of week 0
# statistical trend p≤0.07 compared to corresponding values of week 0
† p≤0.05 change from week 0 compared to AD
• p≤0.05 change from week 0 compared to SE
Blood lactate concentrations at sub-maximal intensities during the incremental cycling test performed prior to (0), at 12 weeks and at 24 weeks following ES, SE and AD.
| Blood lactate (mmol L-1) | |||||||
|---|---|---|---|---|---|---|---|
| 50W | 75W | 100W | 125W | 150W | 175W | ||
|
|
| ||||||
| 0 | 1.3±0.5 | 1.3±0.5 | 1.6±0.5 | 1.9±0.8 | 2.7±1.1 | 3.4±1.5 | |
| 12 | 1.2±0.3 | 1.3±0.3 | 1.4±0.4 | 1.8±0.5 | 2.3±0.7 | 2.9±1.1 | |
| 24 | 1.2±0.5 | 1.1±0.5 | 1.3±0.5 | 1.6±0.7 | 2.0±1.0 | 2.8±1.4 | |
|
| |||||||
| 0 | 1.8±0.5 | 1.8±0.5 | 2.2±0.5 | 3.0±1.0 | 4.1±2.0 | 4.7±1.7 | |
| 12 | 1.3±0.4 | 1.5±0.4 | 1.8±0.4 | 2.3±0.7 | 3.1±1.1 | 4.0±1.7 | |
| 24 | 1.3±0.4 | 1.4±0.4 | 1.6±0.3 | 2.0±0.4 | 2.6±0.7 | 3.3±1.1 | |
|
| |||||||
| 0 | 1.1±0.3 | 1.5±0.5 | 2.1±0.9 | 2.9±1.4 | 3.7±1.0 | 5.1±1.3 | |
| 12 | 1.2±0.3 | 1.3±0.4 | 1.7±0.6 | 2.2±0.8 | 2.8±0.7 | 3.8±0.9 | |
| 24 | 1.3±0.5 | 1.4±0.5 | 1.7±0.7 | 2.1±0.9 | 2.6±0.8 | 3.4±1.0 | |
|
|
| ||||||
| 0 | 1.5±0.4 | 2.1±0.8 | 3.1±1.2 | 4.6±1.8 | |||
| 12 | 1.3±0.2 | 1.7±0.4 | 2.3±0.7 | 3.5±1.3 | |||
| 24 | 1.3±0.2 | 1.7±0.4 | 2.3±0.7 | 3.5±1.3 | |||
|
| |||||||
| 0 | 1.3±0.4 | 1.8±0.5 | 2.6±1.0 | 4.0±1.7 | |||
| 12 | 1.4±0.5 | 1.8±0.9 | 2.3±1.1 | 3.5±1.7 | |||
| 24 | 1.1±0.3 | 1.4±0.5 | 1.9±0.9 | 3.0±1.4 | |||
|
| |||||||
| 0 | 1.1±0.4 | 1.9±0.8 | 3.1±1.1 | 4.7±1.5 | |||
| 12 | 1.1±0.3 | 1.5±0.4 | 2.4±0.8 | 3.5±1.0 | |||
| 24 | 1.4±0.5 | 1.7±0.5 | 2.4±0.7 | 3.4±1.1 | |||
* p≤0.05 compared to corresponding values of week 0
# statistical trend p≤0.06 compared to corresponding values of week 0
† p≤0.05 change from week 0 compared to AD
• p≤0.05 change from week 0 compared to SE